On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
Three new papers converge on a two-cent idea: the neutrophil percentage-to-albumin ratio (NPAR) measures the balance between inflammatory injury and nutritional reserve — tracking both how bad the diabetic foot is now and how the patient fares over years. Plus a clear-eyed look at why AI-driven precision nutrition isn't here yet, and what it will take.
Two diabetic foot data engines published the same day on two continents. STEADY (US) is a 5,000-patient, AI-enabled real-world registry; DARE-DiaFoot (Italy) is a deep, multi-instrumental phenotyping protocol that quietly studies remission. One is the census, the other the core sample. Together with EURODIALE, the U.S. Wound Registry, and the National Diabetes Foot Care Audit, they sketch a blueprint for finally measuring what we manage.
Amputated tissue from the sea cucumber Psolus fabricii healed its own wounds and kept living in plain, non-sterile seawater for more than three years. Jobson et al. in Science Advances on "natural tissue immortality" — and why a wound-healing surgeon can't look away.
Yu and colleagues from Ken Muneoka's group show that sequential FGF2 then BMP2 treatment flips an adult mouse digit amputation from fibrosis to regeneration — rebuilding the distal phalanx with a growth plate, plus a parallel response that regenerates a synovial joint complex with tendon, ligament, and a sesamoid-like bone. The regeneration-competent cells are already in our wound beds. We just have to learn what to say to them.
Our colleagues at the NIDDK Diabetic Foot Consortium have published the methodologic scaffolding the field has needed: a platform study—master-protocol trial design borrowed from oncology and COVID-19 vaccines—applied for the first time to DFU biomarker validation. Their mantra: No DFU Goes Unstudied.
A new review asks whether we can move from patching to regrowing — and what stands between lab-bench organoids and the clinic.
Our new paper in Burns and Trauma presents the most comprehensive review yet of spooky action at a distance therapies for diabetic limb preservation — from spinal cord stimulation and splenic ultrasound to remote ischemic conditioning and tibial transport. Five modalities, three mechanistic pathways, one shared destination: tissue repair at a distance.
A new single-center study from the Netherlands quantifies the devastating outcomes of the diabetic foot attack: only 48.5% wound closure, 46% major amputation by 12 months, 26% one-year mortality, and 12-month amputation-free survival of just 39.7%. Time is tissue.
A new bibliometric analysis from Wei and colleagues at Capital Medical University in Beijing maps 25 years (2000–2024) of global research on plantar pressure and diabetic foot ulcers — over 2,100 publications indexed in the Web of Science Core Collection. The findings tell a story that will feel familiar to many of us who have... Continue Reading →
Chronic wounds are biological computers stuck in a boot loop. Sharp debridement is Control-Alt-Delete — the histological reboot that converts a chronic wound back into an acute one. Only then can you run the apps.
